Early de-escalation of empiric antibiotic therapy in neutropenic fever: a single-center, retrospective study
Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Zachary Mostel1, Michelle Evans1, Douglas Tremblay2
1Division of Infectious Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
Abstract:
We implemented a policy to discontinue empiric antibiotics after 48 hours of defervescence in neutropenic fever with no identified clinical/microbiologic infection. Among patients with acute myeloid leukemia or hematopoietic stem cell transplant, early de-escalation was not associated with increased subsequent infection, decompensation, or mortality, supporting its safety and feasibility.
More Related Videos
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Pyelonephritis I: Introduction
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

